CL
Therapeutic Areas
Mainstay Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ReActiv8® System | Mechanical Chronic Low Back Pain (CLBP) with Multifidus Dysfunction | Post-Market |
Leadership Team at Mainstay Medical
JH
Jason Hannon
Chief Executive Officer and Director
MO
Matt Onaitis
Chief Financial Officer
AT
Andrew Tochterman
Chief Commercial Officer
JY
Jim Youssef, MD
Senior Vice President of Medical and Scientific Affairs
BC
Bryan Cornwall
Senior Vice President, Research and Clinical
LO
Liesl Oldstone
Vice President of Reimbursement and Market Access
DB
David Brownlee
Vice President, Marketing
ET
Elias Tu
Vice President of Sales, United States
HW
Holger Witkowski
Managing Director, Europe
CS
Corey Swift
Vice President of Sales, Australia